Palboxen 125 mg (Palbociclib)

Palboxen 125 mg (Palbociclib) - Targeted Breast Cancer Medicine

Palboxen 125 mg (Palbociclib) is a specialized oral oncology medication used for the targeted treatment of certain types of advanced breast cancer. It is a CDK4/6 inhibitor designed to slow the progression of cancer by interfering with the cell division process.

This medication is manufactured by Everest Pharmaceuticals Ltd., a leading pharmaceutical company in Bangladesh, and is supplied globally by Mediaid Pharmacy. We are dedicated to ensuring that patients and healthcare providers worldwide have reliable access to genuine, high-quality cancer treatments. This product is available for Export Only.

What is Palboxen 125 mg (Palbociclib)?

Palboxen contains the active ingredient Palbociclib. It belongs to a class of drugs known as cyclin-dependent kinase (CDK) 4 and 6 inhibitors.

In hormone receptor-positive breast cancer, proteins called CDK4 and CDK6 are often overactive, signaling cancer cells to grow and divide uncontrollably. Palboxen works by blocking these proteins. By inhibiting CDK4/6, it stops the cancer cells from moving from the "resting" phase (G1) into the "dividing" phase (S), effectively slowing down tumor growth.

Indications for Use

Palboxen 125 mg is indicated for the treatment of adult patients with Hormone Receptor-positive (HR+), Human Epidermal growth factor Receptor 2-negative (HER2-) advanced or metastatic breast cancer.

It is typically used in combination with hormonal therapies:

• With an aromatase inhibitor: As initial endocrine-based therapy in postmenopausal women or in men.
• With fulvestrant: In patients whose disease has progressed following prior endocrine therapy.

Dosage & Administration

Palboxen is taken orally. The treatment follows a specific 28-day cycle.

• Recommended Dose: One 125 mg capsule taken once daily.
• Dosing Cycle: Take the medication for 21 consecutive days, followed by 7 days off (no medication). This completes one 28-day cycle.
• Administration: Palboxen capsules should be taken with food. Swallow the capsule whole; do not chew, crush, or open it.
• Missed Dose: If you vomit or miss a dose, do not take an extra dose. Take your next prescribed dose at the regular time.

Always follow the specific dosage instructions provided by your qualified oncologist.

Manufacturer – Everest Pharmaceuticals Ltd.

Everest Pharmaceuticals Ltd. is a prominent pharmaceutical manufacturer known for its high-tech production of specialized oncology drugs. With facilities that comply with international Good Manufacturing Practices (GMP), Everest ensures that Palboxen is produced to the highest standards of safety, purity, and efficacy.

Supplier – Mediaid Pharmacy

Mediaid Pharmacy is your trusted global supplier and distributor of specialized oncology medicines, including Palboxen 125 mg. We are dedicated to bridging the gap in global healthcare by ensuring patients have access to essential medications.

Mediaid Pharmacy is known for:

• Worldwide Shipping: We securely ship "Export Only" medications to patients, pharmacies, and hospitals across the globe.
• Guaranteed Authenticity: We source Palboxen directly from Everest Pharmaceuticals to ensure you receive 100% genuine products.
• Patient-Centric Service: Our professional team provides dedicated support and ensures a seamless, confidential ordering process.
• Competitive Pricing: We strive to offer affordable solutions for advanced cancer care.

Why Choose Palboxen 125 mg from Mediaid Pharmacy?

• Targeted Mechanism: Specifically inhibits CDK4/6 to stop cancer cell replication.
• Convenient Packaging: The 21-capsule pack size matches the 21-day active treatment phase of the cycle.
• High-Quality Manufacturing: Produced by Everest Pharmaceuticals under strict quality control.
• Global Availability: Distributed efficiently by Mediaid Pharmacy with reliable shipping options.

Frequently Asked Questions (FAQs)

Q: Why are there only 21 capsules in the box?
A: Palbociclib is prescribed on a cycle of 21 days on medication followed by 7 days off. The box contains exactly enough medication for the active dosing period.

Q: Should I take Palboxen with food?
A: Yes, Palboxen capsules should be taken with food to ensure the drug is absorbed properly by your body.

Q: What happens during the 7 days off?
A: During the 7-day break, your body recovers (specifically your blood cell counts). You start the next pack of 21 capsules immediately after the 7 days are over.

Conclusion

Palboxen 125 mg (Palbociclib) is a cornerstone therapy for HR+/HER2- metastatic breast cancer. By targeting the cell cycle, it significantly delays disease progression. Manufactured by Everest Pharmaceuticals and supplied by Mediaid Pharmacy, it offers a high-quality and accessible treatment option for patients worldwide.

Contact Us to Order or Inquire

For the latest pricing, bulk orders, or to speak with our pharmacy team about Palboxen 125 mg (Palbociclib), please contact us. We are available 24/7 to support your healthcare needs.

WhatsApp/WeChat: +8801773428128